Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dideoxynucleosides | 2 | 2018 | 92 | 0.89 | Why? |
| Platelet Membrane Glycoproteins | 1 | 2018 | 42 | 0.74 | Why? |
| Tenofovir | 2 | 2018 | 449 | 0.68 | Why? |
| Collagen | 1 | 2018 | 222 | 0.64 | Why? |
| Bone Density | 2 | 2017 | 335 | 0.63 | Why? |
| Drug Substitution | 1 | 2018 | 385 | 0.56 | Why? |
| HIV Infections | 10 | 2020 | 11620 | 0.54 | Why? |
| Anti-Retroviral Agents | 4 | 2020 | 1099 | 0.49 | Why? |
| von Willebrand Factor | 4 | 2021 | 668 | 0.44 | Why? |
| Osteoporosis | 1 | 2016 | 410 | 0.42 | Why? |
| Fractures, Bone | 1 | 2016 | 487 | 0.41 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 9335 | 0.38 | Why? |
| Ireland | 5 | 2020 | 1456 | 0.37 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.29 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.28 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.25 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.25 | Why? |
| Multicenter Studies as Topic | 2 | 2020 | 2437 | 0.25 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.22 | Why? |
| P-Selectin | 2 | 2021 | 224 | 0.21 | Why? |
| Absorptiometry, Photon | 2 | 2017 | 168 | 0.19 | Why? |
| Blood Platelets | 2 | 2021 | 1704 | 0.18 | Why? |
| CD40 Antigens | 1 | 2018 | 118 | 0.17 | Why? |
| Heterosexuality | 1 | 2018 | 148 | 0.17 | Why? |
| Emtricitabine | 1 | 2018 | 202 | 0.17 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2020 | 801 | 0.17 | Why? |
| Protein Precursors | 1 | 2020 | 425 | 0.16 | Why? |
| Bone Diseases, Metabolic | 1 | 2017 | 64 | 0.16 | Why? |
| Lamivudine | 1 | 2018 | 210 | 0.16 | Why? |
| Ergocalciferols | 1 | 2016 | 51 | 0.16 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.16 | Why? |
| Cardiovascular Diseases | 2 | 2018 | 11497 | 0.15 | Why? |
| Drug Administration Schedule | 2 | 2020 | 2324 | 0.15 | Why? |
| Adenine | 1 | 2018 | 463 | 0.14 | Why? |
| Bone Density Conservation Agents | 1 | 2016 | 209 | 0.13 | Why? |
| Cholecalciferol | 1 | 2016 | 246 | 0.12 | Why? |
| Aging | 2 | 2018 | 3581 | 0.11 | Why? |
| Prospective Studies | 5 | 2020 | 43301 | 0.11 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.11 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2020 | 10649 | 0.11 | Why? |
| HIV | 1 | 2018 | 1116 | 0.11 | Why? |
| Endothelial Cells | 1 | 2020 | 2048 | 0.10 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.10 | Why? |
| Sexual and Gender Minorities | 1 | 2018 | 1019 | 0.09 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.09 | Why? |
| Coronavirus Infections | 6 | 2021 | 253789 | 0.08 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.08 | Why? |
| Health Status | 1 | 2020 | 3259 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Emigrants and Immigrants | 1 | 2015 | 888 | 0.08 | Why? |
| Humans | 21 | 2021 | 930598 | 0.07 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Inflammatory Bowel Diseases | 1 | 2021 | 3209 | 0.06 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.06 | Why? |
| Thrombospondin 1 | 1 | 2021 | 29 | 0.06 | Why? |
| Protease Inhibitors | 1 | 2018 | 3630 | 0.06 | Why? |
| Thrombopoietin | 1 | 2021 | 52 | 0.06 | Why? |
| Asthma | 1 | 2020 | 4383 | 0.05 | Why? |
| Platelet Function Tests | 1 | 2021 | 231 | 0.05 | Why? |
| Mean Platelet Volume | 1 | 2021 | 203 | 0.05 | Why? |
| Adenosine Triphosphate | 1 | 2021 | 294 | 0.05 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.04 | Why? |
| ADAMTS13 Protein | 1 | 2021 | 363 | 0.04 | Why? |
| Comorbidity | 5 | 2020 | 34796 | 0.04 | Why? |
| Platelet Factor 4 | 1 | 2021 | 385 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2020 | 1517 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Hemostasis | 1 | 2021 | 811 | 0.03 | Why? |
| Female | 10 | 2021 | 380317 | 0.03 | Why? |
| Cultural Characteristics | 1 | 2015 | 159 | 0.03 | Why? |
| Adult | 7 | 2020 | 244371 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.03 | Why? |
| Focus Groups | 1 | 2015 | 811 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2015 | 10697 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.03 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Counseling | 1 | 2015 | 747 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| England | 1 | 2018 | 5116 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Social Stigma | 1 | 2015 | 1049 | 0.02 | Why? |
| Africa | 1 | 2015 | 2986 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.02 | Why? |
| Qualitative Research | 1 | 2015 | 4337 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.01 | Why? |
| United Kingdom | 1 | 2020 | 18046 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Mass Screening | 1 | 2015 | 8005 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Adolescent | 1 | 2015 | 86841 | 0.00 | Why? |
Mallon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(105)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(112)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_